BPC-157 vs AOD-9604: Which Is Better?

Creator: FormBlends Medical Team
Published: 2026-01-23

BPC-157 vs AOD-9604 comparison. Tissue repair peptide vs fat-loss peptide. Different targets and when each is the right choice.

By FormBlends Editorial Research|Source reviewed by FormBlends Medical Team|Last reviewed April 1, 2026|Published January 23, 2026

Source Reviewed

Written by FormBlends Editorial Research · Checked against primary sources by FormBlends Medical Team

Custom header image for BPC-157 vs AOD-9604: Which Is Better?, Peptide Therapy, and better treatment decision-making.

In This Article

This article is part of our Peptide Therapy collection. See also: GLP-1 Guides | Provider Comparisons

Search and AI answer brief

Practical answer: BPC-157 vs AOD-9604: Which Is Better?

BPC-157 vs AOD-9604 comparison. Tissue repair peptide vs fat-loss peptide. Different targets and when each is the right choice.

Short answer

BPC-157 vs AOD-9604 comparison. Tissue repair peptide vs fat-loss peptide. Different targets and when each is the right choice.

Search intent

This page answers a specific Peptide Therapy question rather than a generic overview.

What to verify

semaglutide, peptide evidence quality

How to use it

Use this information to prepare sharper questions for a licensed provider.

Key Takeaway

Researching AOD-9604? See it at FormBlends →

BPC-157 vs AOD-9604 comparison. Tissue repair peptide vs fat-loss peptide. Different targets and when each is the right choice.

Quick Answer: BPC-157 vs AOD-9604 compares a tissue repair peptide with a fat-loss peptide. BPC-157 heals injuries, gut lining, and damaged tissues through growth factor activation. AOD-9604 is a modified fragment of human growth hormone (amino acids 177-191) that stimulates lipolysis (fat breakdown) without the growth-promoting effects of full GH. Choose BPC-157 for healing and AOD-9604 for targeted fat loss. They serve entirely different purposes and can be combined when both goals are relevant .

Comparison

BPC-157 vs AOD-9604
Factor	BPC-157	AOD-9604
Primary role	Tissue repair	Fat loss (lipolysis)
Mechanism	Growth factor upregulation	GH fragment-mediated fat oxidation
Best for	Injuries, gut, tendons	Stubborn fat reduction, body composition
Administration	SC injection near injury	SC injection in fat deposits
Effect on muscle	Muscle repair	No muscle growth (unlike full GH)
Effect on blood sugar	Neutral	Neutral (doesn't raise like full GH)

When to Choose Each

BPC-157: Physical healing is the priority (injuries, gut, post-surgery)
AOD-9604: Targeted fat loss is the priority, particularly stubborn fat areas that resist diet and exercise
Both: Recovering from injury while also working on body composition. They don't interfere with each other

Frequently Asked Questions

Can BPC-157 help with fat loss?

BPC-157 has no direct fat-loss mechanisms. It doesn't stimulate lipolysis or affect metabolic rate. For fat loss, AOD-9604 or GLP-1 agonists are appropriate choices.

From the FormBlends catalog

AOD-9604

Fat-targeting fragment without growth hormone side effects · From $199/mo · compounded by a licensed 503A pharmacy, dispensed only after provider review.

View AOD-9604 →

Popular Therapeutic Peptides by Use Case. Based on published peptide research literature.

View data table

Bar chart showing popular therapeutic peptides by use case: BPC-157 (88), TB-500 (82), Sermorelin (78), Ipamorelin (75), GHK-Cu (70)
Category	Clinical Interest Score	Detail
BPC-157	88	Tissue repair and gut healing
TB-500	82	Injury recovery
Sermorelin	78	Growth hormone support
Ipamorelin	75	Anti-aging and recovery
GHK-Cu	70	Skin and tissue repair

How does AOD-9604 compare to semaglutide for fat loss?

Semaglutide (GLP-1 agonist) produces more dramatic weight loss through appetite suppression and metabolic effects. AOD-9604 provides more modest, targeted fat reduction. Semaglutide has stronger clinical evidence for weight loss.

Heal and Lean Out

At FormBlends, our physicians create protocols addressing both healing and body composition goals.

Schedule Your Free Consultation

Disclaimer: This article is for informational purposes only and doesn't constitute medical advice. Always consult with a licensed healthcare provider. Individual results may vary.

Ready when you are

AOD-9604

Fat-targeting fragment without growth hormone side effects · From $199/mo · compounded by a licensed 503A pharmacy, dispensed only after provider review.

View AOD-9604 →

Browse the full catalog →

Research Snapshot

Head-to-head comparison

Entities covered

FormBlends Semaglutide

Page type

Head-to-head comparison

FormBlends review

Last reviewed

2026-04-01

FormBlends review

FormBlends official source

formblends.com

Official source

Semaglutide evidence source

www.wegovy.com

Official source

Before you act

Check the current prescribing information, regulatory status, and trial source before treating an investigational or newly approved medication as interchangeable with an established therapy.

Check before ordering

Regulatory status, labels, trial records, and sponsor updates can change quickly for obesity-drug pipeline pages. This snapshot is designed to make verification easier, not to replace checking the official source before making a medical or purchase decision. Last page review: 2026-04-01.

Evidence standard

How this page was source-checked

Editorial policy

FormBlends does not claim an individual clinician byline unless a named reviewer is available. For this page, the editorial team checks medical and regulatory claims against primary sources, clinical trials, public datasets, and regulator guidance.

FDA category lists for bulk drug substances

Regulator

Used to distinguish studied peptides from peptides that lack lawful compounding status.

ClinicalTrials.gov

Dataset

Used to separate human trial evidence from animal, mechanistic, or anecdotal claims.

PubMed evidence trail

Research sources used to frame this page

For BPC-157 vs AOD-9604: Which Is Better?, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

ReviewAOD-9604 evidence2001

Effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism in obese and beta3-AR knockout mice

Mouse study; AOD9604 affected fat metabolism in mice, but the subsequent human obesity efficacy trial reported no meaningful weight loss versus placebo.

PubMed

ReviewAOD-9604 evidence2001

Increase of fat oxidation and weight loss in obese mice by a modified C-terminal GH fragment

Obese-mouse study of the AOD9604 fragment; preclinical only, and these effects were not reproduced in human obesity trials.

PubMed

ReviewAOD-9604 evidence2005

Gateways to clinical trials

Drug-pipeline review listing AOD-9604 in clinical development; it was later dropped after human obesity trials failed to show clinically meaningful weight loss.

PubMed

ReviewBPC-157 evidence2025

Multifunctionality and Possible Medical Application of the BPC 157 Peptide

Used to frame BPC-157 as an investigational peptide with mixed preclinical and limited human evidence.

PubMed

ReviewBPC-157 evidence2019

Gastric pentadecapeptide BPC 157 and its role in accelerating musculoskeletal soft tissue healing

Supports cautious tissue-repair context without presenting BPC-157 as an approved therapy.

PubMed

Systematic reviewBPC-157 evidence2025

Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review

Useful for injury-recovery pages where human evidence limits need to be explicit.

PubMed

Comparison decision path

Use this comparison to narrow the provider review question

Direct answer

BPC-157 vs AOD-9604: Which Is Better? should help you decide which option deserves a clinical review, not force a one-size answer.

Start the provider review

Evidence check

A strong comparison should connect mechanism, evidence strength, safety, access, and cost instead of only naming a winner.

Safety check

The right choice can change based on history, medication interactions, side effects, budget, and availability.

Next step

After comparing, use the get-started flow to route your goals and health history into the right prescription review path.

Helpful context before the funnel

All comparisons

Compare nearby medications, providers, and treatment paths.

Product options

Move from comparison to treatment fit.

Cost calculator

Check whether the practical path matches your budget.

FormBlends Editorial Context

Reviewed May 14, 2026

BPC-157 vs AOD-9604 comparison. Tissue repair peptide vs fat-loss peptide. Different targets and when each is the right choice. Read "BPC-157 vs AOD-9604: Which Is Better?" as a peptide therapy guide where research status, sourcing, compounding quality, dosing, and clinician oversight all need extra scrutiny. The main job of this page is comparison and decision support, especially where the topic touches BPC-157. Read the opening answer first, then check the evidence and safety sections before acting on the recommendation. Use it to ask sharper questions of a licensed clinician, not as a substitute for personal medical advice.

Confirm whether the page is discussing an FDA-approved use, a compounded option, or research-only context.
Ask a licensed clinician how the evidence applies to your health history, medications, labs, and side-effect risk.
Check the latest label, trial update, pharmacy policy, or state rule when the article touches medication access.

Original tools and data

Use the FormBlends research stack

These assets are built to be useful beyond a single article: shareable data pages, calculators, provider comparisons, and safety checks that give Google and readers something original to crawl.

2026 GLP-1 Telehealth Report

105 providers scored on price, safety, compliance, and patient experience.

Compounded GLP-1 ZIP Lookup

State pharmacy-board posture and telehealth access for US ZIP codes.

America on GLP-1 Map

County-level adoption estimates using CDC, Census, and KFF inputs.

Editorial refresh

Practical 2026 note for BPC

This update makes BPC more specific by tying semaglutide, BPC-157, bpc, 157, aod, 9604 to the page's original clinical, cost, access, or comparison angle.

The goal is to make the article more useful for people who already know the headline question and need page-level specifics, not another interchangeable peptide therapy summary.

For 2026 review, the content emphasizes current verification, treatment fit, and patient-safety questions that can be discussed with a qualified provider.

BPC custom 2026 image for peptide therapy on FormBlends — Image description: Unique image for this page covering BPC, peptide therapy, safety, cost, provider selection, and patient decision-making.

Download the Peptide Quick Reference Card

A printable 2-page reference covering popular peptides, dosing ranges, stacking protocols, and storage.

Free download. We'll also send helpful GLP-1 guides to your inbox. Unsubscribe anytime.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are source-checked against medical and regulatory references, but they are not a substitute for a personal medical consultation.

Written by FormBlends Editorial Research

Prepared by FormBlends Editorial Research. Claims are checked against primary regulatory, trial, label, and public-health sources where available. Reviewed by FormBlends Medical Team for medical accuracy, sourcing, and patient-safety framing.

BPC-157 vs AOD-9604: Which Is Better?

Practical answer: BPC-157 vs AOD-9604: Which Is Better?

Comparison

When to Choose Each

Frequently Asked Questions

Can BPC-157 help with fat loss?

How does AOD-9604 compare to semaglutide for fat loss?

Heal and Lean Out

Research Snapshot

How this page was source-checked

Research sources used to frame this page

Use this comparison to narrow the provider review question

FormBlends Editorial Context

Use the FormBlends research stack

Practical 2026 note for BPC

Download the Peptide Quick Reference Card

Ready to Start Your Weight Loss Journey?

Next Best Reads

BPC-157 vs CJC-1295: Which Is Better?

BPC-157 vs Epithalon: Which Is Better?

BPC-157 vs GHK-Cu: Which Is Better?

BPC-157 vs Glutathione: Which Is Better?

BPC-157 vs Ipamorelin: Which Is Better?

BPC-157 vs Kisspeptin: Which Is Better?

Free Tools

BMI Calculator

Cost Calculator

Drug Interaction Checker

Dosing Schedule

Helpful Content